A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory …

H Lavretsky, KT Laird, B Krause-Sorio… - The American Journal of …, 2020 - Elsevier
Objective Geriatric depression is difficult to treat and frequently accompanied by cognitive
complaints that increase risk for dementia. New treatment strategies targeting both …

Combined treatment with memantine/es‐citalopram for older depressed patients with cognitive impairment: a pilot study

GH Pelton, OL Harper, SP Roose… - … journal of geriatric …, 2016 - Wiley Online Library
Objective The objective of the study is to assess combined antidepressant and memantine
treatment in older patients presenting with depression and cognitive impairment. Methods …

Escitalopram prevents relapse in older patients with major depressive disorder

P Gorwood, E Weiller, O Lemming, C Katona - The American journal of …, 2007 - Elsevier
Objective The present study investigated the efficacy and tolerability of escitalopram in the
prevention of relapse of major depressive disorder (MDD) in older patients who had …

Escitalopram in the treatment of depressed elderly patients

S Kasper, H de Swart, HF Andersen - The American journal of geriatric …, 2005 - Elsevier
Objective Management of depression in elderly patients presents a significant medical
challenge, and there is a need for further clinical trials. The authors examined the efficacy …

Escitalopram in the acute treatment of depressed patients aged 60 years or older

A Bose, D Li, C Gandhi - The American Journal of Geriatric Psychiatry, 2008 - Elsevier
Objective The present study examined the efficacy and tolerability of acute escitalopram
treatment in depressed patients aged 60 years or older. Methods Patients aged≥ 60 years …

Predicting 6‐week treatment response to escitalopram pharmacotherapy in late‐life major depressive disorder

R Saghafi, C Brown, MA Butters… - … Journal of Geriatric …, 2007 - Wiley Online Library
Objective Approximately half of older patients treated for major depressive disorder (MDD)
do not achieve symptomatic remission and functional recovery with first‐line …

Escitalopram for comorbid depression and anxiety in elderly patients: a 12-week, open-label, flexible-dose, pilot trial

S Mohamed, K Osatuke, M Aslam, J Kasckow - The American Journal of …, 2006 - Elsevier
BACKGROUND:: Comorbid depression and anxiety may result in greater symptom severity
and poorer treatment response than either condition alone. Selective serotonin reuptake …

Escitalopram in the long-term treatment of major depressive disorder in elderly patients

S Kasper, OM Lemming, H de Swart - Neuropsychobiology, 2007 - karger.com
Aim: The primary aim was to investigate the long-term safety and tolerability of escitalopram
(10 or 20 mg/day) treatment of elderly patients suffering from major depressive disorder. The …

Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with …

CF Reynolds III, MA Dew, LM Martire… - … journal of geriatric …, 2010 - Wiley Online Library
Objective More than half of the older adults respond only partially to first‐line antidepressant
pharmacotherapy. Our objective was to test the hypothesis that a depression‐specific …

Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot …

GH Pelton, OL Harper, MH Tabert… - … Journal of Geriatric …, 2008 - Wiley Online Library
Objective To assess combined antidepressant and cognitive enhancer treatment in elderly
patients presenting with depression plus cognitive impairment. Methods Twenty‐three …